Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Imaging apoptosis in living repTOP™ reporter mice with VivoGlo™ Caspase-3/7 Substrate (Z-DEVD-Aminoluciferin, Sodium Salt)

Part # PS102

Abstract

VivoGlo™ Caspase-3/7 Substrate (Z-DEVD-Aminoluciferin, Sodium Salt) is a firefly luciferase prosubstrate containing the DEVD tetrapeptide sequence recognized by caspase-3 and -7. Upon activation of caspase-3 or -7, the DEVD peptide is cleaved, and the liberated aminoluciferin reacts with luciferase.

VivoGlo™ Caspase-3/7 Substrate was designed to study the apoptotic pathway in vivo in mice. It has a minimum solubility of 500mg/ml in PBS, and the resulting solution is stable for at least 3 days at room temperature. Injection is usually done via the intraperitoneal route and imaging is generally started 10 minutes after injection.

These two novel technologies, repTOP™ mice and VivoGlo™ Caspase- 3/7 Substrate make it possible, for the first time, to see where and when Caspase-3/7 is active in living mice.

Printed in USA.